191 related articles for article (PubMed ID: 30569343)
1. Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines.
Breitbach GP; Sklavounos P; Veith C; Costa SD; Kuhn W; Solomayer EF; Juhasz-Boess I; Tempfer C
Arch Gynecol Obstet; 2019 Apr; 299(4):1115-1119. PubMed ID: 30569343
[TBL] [Abstract][Full Text] [Related]
2. A Successfully Treated Metastatic Choriocarcinoma Coexistent With Pregnancy: A Case Report of a 4-Year Follow-Up.
Yu P; Diao W; Jiang X
Medicine (Baltimore); 2016 May; 95(21):e3505. PubMed ID: 27227917
[TBL] [Abstract][Full Text] [Related]
3. Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
Hiramatsu Y; Masuyama H; Ishida M; Murakami K; Sakurai M
Acta Med Okayama; 2005 Oct; 59(5):235-8. PubMed ID: 16286962
[TBL] [Abstract][Full Text] [Related]
4. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Newlands ES
Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
[TBL] [Abstract][Full Text] [Related]
5. Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report.
Schuman S; Pearson JM; Lucci JA; Twiggs LB
J Reprod Med; 2010; 55(9-10):441-4. PubMed ID: 21043373
[TBL] [Abstract][Full Text] [Related]
6. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review.
Huang CY; Chen CA; Hsieh CY; Cheng WF
Int J Gynecol Cancer; 2007; 17(5):1166-71. PubMed ID: 17425677
[TBL] [Abstract][Full Text] [Related]
8. Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
Hsieh TY; Hsu KF; Kuo PL; Huang SC
J Obstet Gynaecol Res; 2008 Apr; 34(2):274-8. PubMed ID: 18412797
[TBL] [Abstract][Full Text] [Related]
9. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
Wong LC; Choo YC; Ma HK
Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
Fechtig A; de Dycker RP; Schumacher T; Zajaczkowski T; Neumann RL
Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):235-8. PubMed ID: 1607119
[TBL] [Abstract][Full Text] [Related]
11. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
Bilgin T; Ozan H; Ozuysal S; Ozkan L
Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
[TBL] [Abstract][Full Text] [Related]
12. Choriocarcinoma brain metastasis in a patient in the third trimester: a case report.
Shen C; Ai L; Li K; Cao Y; Wu H; Sun D
J Med Case Rep; 2021 Jul; 15(1):417. PubMed ID: 34325722
[TBL] [Abstract][Full Text] [Related]
13. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
14. Role of chemotherapy and thrombolysis in treatment of choriocarcinoma accompanied with pulmonary embolism: A case report with literature review.
Yang M; Peng L
Medicine (Baltimore); 2017 Sep; 96(36):e7866. PubMed ID: 28885339
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report.
Das SK; Shahi A; Panthi RC
JNMA J Nepal Med Assoc; 2022 May; 60(249):488-490. PubMed ID: 35633247
[TBL] [Abstract][Full Text] [Related]
16. Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.
Popadiuk C; Power P
J Reprod Med; 2016; 61(5-6):215-8. PubMed ID: 27424361
[TBL] [Abstract][Full Text] [Related]
17. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
Turan T; Karacay O; Tulunay G; Boran N; Koc S; Bozok S; Kose MF
Int J Gynecol Cancer; 2006; 16(3):1432-8. PubMed ID: 16803542
[TBL] [Abstract][Full Text] [Related]
18. Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Behtash N; Behnamfar F; Hamedi B; Ramezanzadeh F
Arch Gynecol Obstet; 2009 Apr; 279(4):579-81. PubMed ID: 18726607
[TBL] [Abstract][Full Text] [Related]
19. Choriocarcinoma with pulmonary metastasis: report of a case of successful treatment with serial FDG-PET follow-up.
Chang WC; Hung YC; Shen HP; Kao CH
J Reprod Med; 2007 May; 52(5):450-2. PubMed ID: 17583253
[TBL] [Abstract][Full Text] [Related]
20. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
